MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • 2025 International Congress

    National Survey of DYT/PARK-GCH1 (Segawa Disease) in Japan

    K. Hoshino, M. Kawai, Y. Nagao, M. Nozaki, Y. Yatomi, Y. Hirano, M. Fukumizu, I. Kawahata, H. Shintaku, K. Kimura, M. Hayashi (Osaka, Japan)

    Objective: To clarify clinical features of Segawa Disease (SD) in Japan. Background: Prof Segawa discovered SD 50 years ago, and GCH-1 gene mutations were linked…
  • 2025 International Congress

    Long-Term Therapeutic Effect of Botulinum Neurotoxin Type A (BoNT-A) in Cervical Dystonia: A Case Series.

    R. Lopez-Castellanos, R. Lopez-Contreras (Boston, USA)

    Objective: To evaluate the long-term therapeutic effect of Botulinum neurotoxin type A (BoNT-A) in cervical dystonia. Background: Cervical dystonia is the most common adult-onset focal…
  • 2025 International Congress

    The Vodka Trial: Clinical and Genetic Characteristics of Alcohol Responsiveness in Laryngeal Dystonia

    L. O'Flynn, A. Domingo, A. Hamzehei Sichani, A. Nishiyama, M. Hincher, R. Yadav, L. Ozelius, K. Simonyan (Boston, USA)

    Objective: To determine the objective characteristics of alcohol responsiveness in laryngeal dystonia (LD) using a standardized alcohol challenge test and genetic testing. Background: LD is…
  • 2025 International Congress

    GPi-DBS responsive laryngeal dystonia in SGCE myoclonus-dystonia

    S. Nagaratnam, D. Wilson, L. Williams, S. Xi, L. Natsis, J. Mcmaster, N. Mahant (Westmead, Australia)

    Objective: To describe a case of DBS-responsive laryngeal dystonia in the setting of myoclonus-dystonia secondary to e-sarcoglycan (SGCE) mutation. Background: DBS is emerging as a…
  • 2025 International Congress

    Understanding Family and Clinician Perspectives on Treatment Decision-Making for Acute Dystonia Exacerbations in Children

    L. Vogt, A. Leblanc-Millar, S. Breitbart, N. Al Azri, A. Fasano, K. Nelson, C. Gorodetsky (Toronto, Canada)

    Objective: Primary: To identify factors influencing the decision to provide acute pharmacological treatment for dystonia exacerbations in hospitalized pediatric patients. Secondary: To assess the alignment…
  • 2025 International Congress

    Development and Testing of a Smartphone Application to Capture Patient-Centered Outcome (PCO) Measures for Dystonia

    P. Reyes, A. Tingin, B. Berman, S. Schneider, J. Hieshetter, K. Kuman, G. Kilic-Berkmen, L. Wright, F. Qeadan, J. Perlmutter, H. Jinnah, S. Pirio-Richardson (Richmond, USA)

    Objective: Develop a smartphone application to collect patient-centered outcome (PCO) measures for dystonia. Background: PCO measures tailored for each major adult-onset focal dystonia subtype (Cervical…
  • 2025 International Congress

    Pilot Study: Shear Wave Elastography as a Potential Biomarker in Task-Specific Dystonia

    A. Ly, A. Mushtaheed, A. Roberts, M. Druckenbrod, J. Stowers, M. Soliman, P. Lind, Y. Assefa, C. Stanley, A. Gravunder, J. Matsubara, C. Zampieri-Gallagher, D. Ehrlich, B. Karp, F. Gavelli, K. Alter (Bethesda, USA)

    Objective: The purpose of this study was to explore shear wave elastography (SWE)’s ability to identify task-specific dystonic muscles by determining if muscle stiffness increased…
  • 2025 International Congress

    Exploring Pallidothalamotractotomy as an Option for Management of Refractory Dystonia following Failure of Pallidotomy

    A. Adhya, D. Garg, D. Radhakrishnan, A. Das, E. Arun, R. Rajan, A. Garg, A. Srivastava, K. Garg (New Delhi, India)

    Objective: To assess the efficacy and safety of PTT as a rescue procedure after pallidotomy in two patients with refractory dystonia. Background: In cases of…
  • 2025 International Congress

    Central Neuromodulatory Effects of Sodium Oxybate in Laryngeal Dystonia: A Pharmacological fMRI Study

    L. O'Flynn, A. Hamzehei Sichani, A. Worthley, N. Sharma, P. Song, K. Simonyan (Boston, USA)

    Objective: To examine the central effects of sodium oxybate in patients with alcohol-responsive (EtOH+) laryngeal dystonia (LD). Background: LD is a task-specific form of isolated…
  • 2025 International Congress

    Cerebrotendinous Xanthomatosis successfully treated with Chenodeoxycholic Acid Supplementation

    N. de Jong, J. Carr, D. Marais (Cape Town, South Africa)

    Objective: To describe the clinical, radiological, laboratory and genetic findings of a patient with Cerebrotendinous Xanthomatosis (CTX) who presented with dystonic tremor initially and subsequently…
  • 1
  • 2
  • 3
  • …
  • 39
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28953 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley